The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the ...

Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to the gut. It reshapes nutrient availability for intestinal bacteria, forcing ...

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus chemotherapy over six years. The combination therapy was particularly ...

A mother is taking legal action against the NHS after receiving six years of unnecessary chemotherapy. Samantha Smith, 45, ...

Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...

David Bown, now 41, is suing the NHS following the mistake which meant he endured years of the powerful therapy, and says he now 'cries himself to sleep '. He said he has been left with irreversible ...

David Bown, 41, was prescribed the drug temozolomide by University Hospitals Coventry and Warwickshire NHS Trust for over eight years, with his lawyers claiming the prolonged treatment has left him wi ...